Cost-Effectiveness Analysis of Long-acting Injectable Once-monthly of Aripiprazole Compared with Long-acting Injectable Once-monthly Paliperidone Palmitate for the Treatment of Stable Schizophrenia Patients in Thailand

Objective: Long-acting injectable (LAI)-aripiprazole and LAI-paliperidone palmitate are both second-generation antipsychotics that have been introduced to increase drug compliance in patients. These attributes are expected to enhance drug compliance, particularly in stable patients. The previous st...

Full description

Bibliographic Details

Main Authors:	Piyanut Ueapanjasin, Wiwat Thavornwattanayong, Jadesada Lertsirimunkong, Kamolpat Chaiyakittisopon
Format:	Artigo
Language:	Inglês
Published:	Faculty of Medicine Siriraj Hospital 2023-10-01
Series:	Siriraj Medical Journal
Subjects:	Aripiprazole cost-effectiveness long-acting injectable antipsychotics paliperidone stable schizophrenia patients
Online Access:	https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/264770
Tags:	Add Tag No Tags, Be the first to tag this record!